77 related articles for article (PubMed ID: 22572578)
1. Structure-activity relationship of a series of non peptidic RGD integrin antagonists targeting α5β1: part 2.
Delouvrié B; Al-Kadhimi K; Arnould JC; Barry ST; Cross DA; Didelot M; Gavine PR; Germain H; Harris CS; Hughes AM; Jude DA; Kendrew J; Lambert-van der Brempt C; Lohmann JJ; Ménard M; Mortlock AA; Pass M; Rooney C; Vautier M; Vincent JL; Warin N
Bioorg Med Chem Lett; 2012 Jun; 22(12):4117-21. PubMed ID: 22572578
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship of a series of non peptidic RGD integrin antagonists targeting α5β1: part 1.
Delouvrié B; Al-Kadhimi K; Arnould JC; Barry ST; Cross DA; Didelot M; Gavine PR; Germain H; Harris CS; Hughes AM; Jude DA; Kendrew J; Lambert-van der Brempt C; Lohmann JJ; Ménard M; Mortlock AA; Pass M; Rooney C; Vautier M; Vincent JL; Warin N
Bioorg Med Chem Lett; 2012 Jun; 22(12):4111-6. PubMed ID: 22575869
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and biological evaluation of non-peptide alpha(v)beta(3)/alpha(5)beta(1) integrin dual antagonists containing 5,6-dihydropyridin-2-one scaffolds.
Benfatti F; Cardillo G; Fabbroni S; Galzerano P; Gentilucci L; Juris R; Tolomelli A; Baiula M; Spartà A; Spampinato S
Bioorg Med Chem; 2007 Dec; 15(23):7380-90. PubMed ID: 17869121
[TBL] [Abstract][Full Text] [Related]
4. Role of α5β1 and αvβ3 integrins in relation to adhesion and spreading dynamics of prostate cancer cells interacting with fibronectin under in vitro conditions.
Stachurska A; Elbanowski J; Kowalczyńska HM
Cell Biol Int; 2012 Oct; 36(10):883-92. PubMed ID: 22686483
[TBL] [Abstract][Full Text] [Related]
5. Non-peptide alpha(v)beta(3) antagonists. Part 4: potent and orally bioavailable chain-shortened RGD mimetics.
Coleman PJ; Askew BC; Hutchinson JH; Whitman DB; Perkins JJ; Hartman GD; Rodan GA; Leu CT; Prueksaritanont T; Fernandez-Metzler C; Merkle KM; Lynch R; Lynch JJ; Rodan SB; Duggan ME
Bioorg Med Chem Lett; 2002 Sep; 12(17):2463-5. PubMed ID: 12161158
[TBL] [Abstract][Full Text] [Related]
6. Regulation of alpha5beta1 integrin conformation and function by urokinase receptor binding.
Wei Y; Czekay RP; Robillard L; Kugler MC; Zhang F; Kim KK; Xiong JP; Humphries MJ; Chapman HA
J Cell Biol; 2005 Jan; 168(3):501-11. PubMed ID: 15684035
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of cancer cell adhesion by heterochiral Pro-containing RGD mimetics.
Gentilucci L; Cardillo G; Squassabia F; Tolomelli A; Spampinato S; Sparta A; Baiula M
Bioorg Med Chem Lett; 2007 Apr; 17(8):2329-33. PubMed ID: 17289386
[TBL] [Abstract][Full Text] [Related]
8. Biselectivity of isoDGR peptides for fibronectin binding integrin subtypes α5β1 and αvβ6: conformational control through flanking amino acids.
Bochen A; Marelli UK; Otto E; Pallarola D; Mas-Moruno C; Di Leva FS; Boehm H; Spatz JP; Novellino E; Kessler H; Marinelli L
J Med Chem; 2013 Feb; 56(4):1509-19. PubMed ID: 23362923
[TBL] [Abstract][Full Text] [Related]
9. Development of isoxazoline-containing peptidomimetics as dual αvβ3 and α5β1 integrin ligands.
Tolomelli A; Gentilucci L; Mosconi E; Viola A; Dattoli SD; Baiula M; Spampinato S; Belvisi L; Civera M
ChemMedChem; 2011 Dec; 6(12):2264-72. PubMed ID: 21953988
[TBL] [Abstract][Full Text] [Related]
10. Design and synthesis of a new class of selective integrin alpha5beta1 antagonists.
Stragies R; Osterkamp F; Zischinsky G; Vossmeyer D; Kalkhof H; Reimer U; Zahn G
J Med Chem; 2007 Aug; 50(16):3786-94. PubMed ID: 17616113
[TBL] [Abstract][Full Text] [Related]
11. Side chain effect in the modulation of α
Ferrazzano L; Corbisiero D; Potenza E; Baiula M; Dattoli SD; Spampinato S; Belvisi L; Civera M; Tolomelli A
Sci Rep; 2020 May; 10(1):7410. PubMed ID: 32366988
[TBL] [Abstract][Full Text] [Related]
12. Nonpeptide alpha(v)beta(3) antagonists. Part 2: constrained glycyl amides derived from the RGD tripeptide.
Meissner RS; Perkins JJ; Duong LT; Hartman GD; Hoffman WF; Huff JR; Ihle NC; Leu CT; Nagy RM; Naylor-Olsen A; Rodan GA; Rodan SB; Whitman DB; Wesolowski GA; Duggan ME
Bioorg Med Chem Lett; 2002 Jan; 12(1):25-9. PubMed ID: 11738566
[TBL] [Abstract][Full Text] [Related]
13. Modulation of αvβ₃- and α₅β₁-integrin-mediated adhesion by dehydro-β-amino acids containing peptidomimetics.
Tolomelli A; Baiula M; Belvisi L; Viola A; Gentilucci L; Troisi S; Dattoli SD; Spampinato S; Civera M; Juaristi E; Escudero M
Eur J Med Chem; 2013 Aug; 66():258-68. PubMed ID: 23811088
[TBL] [Abstract][Full Text] [Related]
14. Antiangiogenic effect of dual/selective alpha(5)beta(1)/alpha(v)beta(3) integrin antagonists designed on partially modified retro-inverso cyclotetrapeptide mimetics.
Gentilucci L; Cardillo G; Spampinato S; Tolomelli A; Squassabia F; De Marco R; Bedini A; Baiula M; Belvisi L; Civera M
J Med Chem; 2010 Jan; 53(1):106-18. PubMed ID: 20055426
[TBL] [Abstract][Full Text] [Related]
15. Nonpeptide RGD antagonists: a novel class of mimetics, the 5,8-disubstituted 1-azabicyclo[5.2.0]nonan-2-one lactam.
Bourguet E; Banères JL; Parello J; Lusinchi X; Girard JP; Vidal JP
Bioorg Med Chem Lett; 2003 May; 13(9):1561-4. PubMed ID: 12699755
[TBL] [Abstract][Full Text] [Related]
16. Rational design of highly active and selective ligands for the alpha5beta1 integrin receptor.
Heckmann D; Meyer A; Laufer B; Zahn G; Stragies R; Kessler H
Chembiochem; 2008 Jun; 9(9):1397-407. PubMed ID: 18481343
[TBL] [Abstract][Full Text] [Related]
17. Disruption of integrin-fibronectin complexes by allosteric but not ligand-mimetic inhibitors.
Mould AP; Craig SE; Byron SK; Humphries MJ; Jowitt TA
Biochem J; 2014 Dec; 464(3):301-13. PubMed ID: 25333419
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a novel nonphosphorylated pentapeptide motif displaying high affinity for Grb2-SH2 domain by the utilization of 3'-substituted tyrosine derivatives.
Song YL; Peach ML; Roller PP; Qiu S; Wang S; Long YQ
J Med Chem; 2006 Mar; 49(5):1585-96. PubMed ID: 16509576
[TBL] [Abstract][Full Text] [Related]
19. Ligand binding analysis for human alpha5beta1 integrin: strategies for designing new alpha5beta1 integrin antagonists.
Marinelli L; Meyer A; Heckmann D; Lavecchia A; Novellino E; Kessler H
J Med Chem; 2005 Jun; 48(13):4204-7. PubMed ID: 15974570
[TBL] [Abstract][Full Text] [Related]
20. A novel integrin alpha5beta1 antagonistic peptide, A5-1, screened by Protein Chip system as a potent angiogenesis inhibitor.
Kim EY; Bang JY; Chang SI; Kang IC
Biochem Biophys Res Commun; 2008 Dec; 377(4):1288-93. PubMed ID: 18996355
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
